Ibsrela 50 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FAKNH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,896
Award facts
- Contract value 100% obligated
- $15,896.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 20, 2026, the Defense Logistics Agency awarded a delivery order valued at $15,896.16 to AmerisourceBergen Drug Corp for the supply of Ibsrela 50 mg tablets (60-count unit doses). This firm fixed-price delivery order represents a competitively awarded, non-set-aside procurement supporting federal medical supply requirements. The award is executed under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical and medical commodities to military healthcare systems globally.
The delivery order is scheduled for completion by January 21, 2026, with the place of performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen, operating through its parent company Cencora, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates capability in fulfilling diverse pharmaceutical requirements across multiple therapeutic domains, including specialty medications, generic and brand-name drugs, vaccines, and medical supplies necessary for military treatment facilities and federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FAKNH?
SPE2DR26FAKNH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FAKNH worth?
The government has obligated $15,896 on SPE2DR26FAKNH.
Is contract SPE2DR26FAKNH an order under another contract?
Yes. SPE2DR26FAKNH is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKNH competed?
The extent of competition for SPE2DR26FAKNH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award